OncoHealth, Blue Note Therapeutics partner to provide a digital therapeutic for cancer-related anxiety and depression

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Blue Note Therapeutics and OncoHealth have partnered to deliver oncology-specific mental health care.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Depression and anxiety are thought to increase a person’s risk of developing cancer, but research results have been inconclusive. In an analysis of multiple studies from the Netherlands, the United Kingdom, Norway, and Canada, investigators found that depression and anxiety are not linked to higher risks for most types of cancer among this population. The analysis is published in Cancer.

Login